Omegaven
Overview
|
WikiDoc Resources for Omegaven |
|
Articles |
|---|
|
Most recent articles on Omegaven |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Omegaven at Clinical Trials.gov Clinical Trials on Omegaven at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Omegaven
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Omegaven Risk calculators and risk factors for Omegaven
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Omegaven |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Omegaven is a fatty acid emulsion produced by Fresenius Kabi. It is used for total parenteral nutrition (feeding directly into a venous catheter), e.g. in short bowel syndrome. It is rich in omega-3 fatty acids.
It has gained popularity in children in preference to the more commonly used Intralipid after case reports that it reduced the risk of liver damage.[1]
A recent study indicated that the use of Omegaven may be an appropriate intervention strategy for newborns with a very low birth weight, gastrochisis, and jejunal atresia.[2]
It is currently undergoing a clinical trial at National Taiwan University Hospital.[3]
Although the use of Omegaven in children in the United States is experimental, the use of it in adults in Europe is less controversial.[4] In European studies, Omegaven has been associated with a reduction in psoriasis, when contrasted to administration of omega-6 fatty acid Lipoven.[5] Omegaven has also been associated with reduced mortality and antibiotic use during hospital stays.[6]
References
- ↑ Gura KM, Duggan CP, Collier SB; et al. (2006). "Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management". Pediatrics. 118 (1): e197–201. doi:10.1542/peds.2005-2662. PMID 16818533.
- ↑ Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK (2007). "Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease". Journal of perinatology : official journal of the California Perinatal Association. 27 (5): 284–90. doi:10.1038/sj.jp.7211686. PMID 17344923.
- ↑ Template:ClinicalTrials
- ↑ A Doctor's Push For Drug Pits Him Against Its Maker at Wall Street Journal
- ↑ Mayser P, Grimm H, Grimminger F (2002). "n-3 fatty acids in psoriasis". Br. J. Nutr. 87 Suppl 1: S77–82. PMID 11895157.
- ↑ Heller AR, Rössler S, Litz RJ; et al. (2006). "Omega-3 fatty acids improve the diagnosis-related clinical outcome". Crit. Care Med. 34 (4): 972–9. doi:10.1097/01.CCM.0000206309.83570.45. PMID 16484909.
External links
- Cooke, Robert (2006-07-03). "How fish oil may have saved babies' lives" (HTML). The Boston Globe. Retrieved 2007-08-22.
- "Fishing for the Right Solution" at Children's Hospital Boston
- "The Right Kind of Oil" at Children's Hospital Boston
- Team on a Mission at Toronto Star